Avidity Biosciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $860 | $12,475 | $3,847 | $1,573 |
Gross Profit | -636 | 11,419 | 3,033 | 788 |
EBITDA | -252,982 | -187,750 | -170,328 | -130,732 |
EBIT | -254,478 | -188,806 | -171,142 | -131,517 |
Net Income | -237,101 | -174,442 | -157,315 | -115,773 |
Net Change In Cash | 860 | 12,475 | 3,847 | 1,573 |
Free Cash Flow | -175,284 | -156,885 | -203,009 | -128,582 |
Cash | 382,517 | 350,158 | 243,907 | 254,203 |
Basic Shares | 149,273 | 137,895 | 129,622 | 129,232 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $18,755 | $10,897 | $9,560 | $9,224 |
Gross Profit | 14,604 | 8,121 | 7,459 | 7,837 |
EBITDA | -741,792 | -376,160 | -233,497 | -177,526 |
EBIT | -745,943 | -378,936 | -235,598 | -178,913 |
Net Income | -684,631 | -322,302 | -212,220 | -173,995 |
Net Change In Cash | 18,755 | 10,897 | 9,560 | 9,224 |
Free Cash Flow | -663,760 | -307,936 | -123,292 | -139,091 |
Cash | 382,517 | 219,868 | 185,082 | 340,396 |
Basic Shares | 137,710 | 111,582 | 73,012 | 52,162 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$1.59 |
2025-09-30 | -$1.27 |
2025-06-30 | -$1.21 |
2025-03-31 | -$0.90 |
